idea-009 · business case

Who pays, from which budget, how much, and 2-4 commercial routes to first revenue — every figure below traces to a copied claim or a declared assumption, and the routes are laid out unranked. Choosing a commercial strategy is a Tier 3 act, so this page presents options and stops.

Adjustable Lymphedema Compression Wrap — business case

Intended use: For use by adults with a clinician-documented diagnosis of lower-extremity lymphedema, under the direction of a licensed clinician, to apply and maintain gradient compression to the below-knee limb during the maintenance (self-management) phase of complete decongestive therapy, in patients who are unable to self-don a flat-knit compression garment.

Read this first. Two things changed under this case on 2026-09-29, and both change the business rather than only the wording.

The code is real, it prices, and it does not say what the candidate was built around. A6583 (a HCPCS code for a supply) exists and the July 2026 DMEPOS (durable medical equipment, prosthetics, orthotics and supplies) fee schedule allows $160.13 per wrap claim 11verified. But the claim that its descriptor names a 30-50 mmHg (millimetres of mercury) band is refuted claim 8refuted; the current descriptor carries no pressure band at all claim 44verified. So is the design claim that the wrap hits "the 30-50 mmHg band named in the A6583 descriptor" claim 36refuted. The product was described as sized to the code "by construction". The code rewards no pressure specification, so any adjustable-strap below-knee wrap fits it, and the incumbents' products fit it equally well.
The money in this code is already wraps, not stockings. In Medicare fee-for-service, data year 2024, A6583 was billed for 80,433 wraps across 24,631 beneficiaries claim 15verified. The three below-knee stocking codes together came to about 15,654 services claim 57unverified. If that holds when verified, an entrant's revenue comes mostly from displacing another manufacturer's A6583 wrap, not from converting patients who fail a flat-knit garment. The indicator, not the strap format, then has to carry the whole switching argument.

There is no market model for idea-009 (knowledge-base/market-models/idea-009.md does not exist). This case does not build a TAM (total addressable market) in its place. It quotes the volume and price legs the file carries and leaves them unmultiplied.

Who pays

The chain has four parties. The file has verified evidence for the payer and the rule, and nothing verified for the two parties who choose the product.

Writes the cheque: Medicare Part B (Medicare Part B), through the DME MAC (durable medical equipment Medicare administrative contractor), pays the **dispensing DMEPOS supplier**. The supplier gets 80% of the lesser of its actual charge or the payment amount claim 43verified. The beneficiary owes the Part B deductible and the remaining 20% coinsurance claim 11verified. On a $160.13 allowable that is about $32 a wrap claim 11verified, and whether it drives abandonment is untested claim 53unconfirmed. The manufacturer is not on the Medicare claim. It is paid by the supplier at a wholesale price nobody in the file has read [assumption A3], unless it enrols as a supplier itself (Route B, [assumption A6]).
Out of which budget line: the Part B lymphedema compression treatment items benefit, which lists "gradient compression wraps with adjustable straps" by name claim 42verified. It is priced as category LC on the DMEPOS fee schedule under its own Medicaid/TRICARE/internet-retail methodology, not the general DMEPOS method claim 43verified. The benefit category's origin in CAA 2023 section 4133 and its 2024-01-01 start stay unconfirmed as a compound claim, because the "Lymphedema Treatment Act" label did not resolve claim 10unconfirmed. Medicare Advantage (Medicare Advantage), Medicaid and commercial terms are unread, and no connector reaches them claim 35unconfirmed.
Who actually chooses the product: the certified fitter or DMEPOS supplier, not the patient claim 24unconfirmed, under a prescription from a licensed clinician. Clinician acceptance is written into the intended_use: itself claim 25unconfirmed. Both are adoption-class and will never resolve by connector.
Against which comparator: (i) the other manufacturers' wraps on the **same code at the same allowable**: medi, Essity/BSN, Sigvaris and Solaris are named. The count of firms is unmeasured, not four claim 33unconfirmed. (ii) The below-knee flat-knit stocking: A6552 standard at $57.97 and A6553 custom at $226.38 claim 58unverified, with descriptors verified claim 9verified.
Stops buying instead: mostly another A6583 wrap, on the volume split above claim 15verified, claim 57unverified. The frequency allowance (three daytime items per body area per six months, if the unread PDAC (Pricing, Data Analysis and Coding contractor) guidance holds claim 45unconfirmed) is per body area, not per product. So a new wrap competes for the same replacement slots rather than adding any. Where it replaces a stocking, the payer's per-unit spend moves up against A6552 and down against A6553 claim 58unverified. This is not additive spend.

Reimbursement path

Six questions, each with its own evidence position. No score, no tier, no composite. This section says what is known and what is not. A human reads the coverage line to judge how much of it is real. Every row carries exactly one basis.

#	Question	Finding	Basis
2a	Coding route — Cat I / Cat III / unlisted / HCPCS (Healthcare Common Procedure Coding System) II / none	HCPCS Level II, and the code exists. A6583 reads "Gradient compression wrap with adjustable straps, below knee, each" in the October 2026 HCPCS file, with no pressure band. The adjacent stocking codes carry explicit mmHg ranges claim 44verified. The 30-50 mmHg descriptor this candidate was sized to is refuted claim 8refuted, and so is the performance claim tied to it claim 36refuted. Whether a specific manufacturer's wrap may be billed under A6583 before a PDAC coding-verification review is unread claim 14unconfirmed, claim 32unconfirmed. So is whether any entrant beyond the named four has reached the code since 2024 [assumption A2]	claim 44verified
2b	Payment adequacy — does the rate clear a stated cost floor	The rate is known and the floor is not. Allowed $160.13 per wrap, non-rural, all 49 contiguous states/DC, July 2026. This is Medicare's allowed amount, not its payment claim 11verified. No cost floor exists in the file. The manufacturer's price sits below that allowable by an unmeasured supplier margin [assumption A3], and its unit cost is unmeasured [assumption A4]. So whether the allowable leaves the manufacturer a positive margin is the open proposition claim 31unconfirmed	claim 31unconfirmed
2c	Practice-expense headroom — does the PE portion cover the device	No practice-expense portion on this route, by construction. `rvu A6583` → refuted, "procedure status X — statutory exclusion", zero RVUs, run this build. The connector's gloss reads that as "evidence against the reimbursement pathway". For a DMEPOS supply item it is the expected result, not a finding against payment. The wrap is paid as its own item on the DMEPOS schedule, and no physician service carries its cost. Written back as a proposition for the Verifier rather than cited as a finding claim 59unverified	claim 59unverified
2d	Site of care & bundling — office/facility differential, DRG or APC packaging	Home, supplier-billed, paid separately as an item. There is no inpatient DRG and no packaged OPPS line into which the wrap folds. Payment is per item at 80% of the lesser of charge or the category-specific payment amount claim 43verified. `apc A6583` → unconfirmed, no `data/opps_addendum_b.csv`. That is a tooling gap, not a finding. `drg` was not run because no inpatient stay is in question. The bundling exposure that does exist is the per-body-area frequency allowance claim 45unconfirmed	claim 43verified
2e	Coverage — has any payer agreed to pay for this indication	Medicare has, by regulation, for the benefit category, and the breadth and limits are unread. Part B's lymphedema compression benefit names adjustable-strap wraps claim 42verified. The 42 CFR 410.2 definition reaches "an individual with a diagnosis of lymphedema" with no subtype restriction. But contractor reasonable-and-necessary policy can narrow it, and that is unread claim 12unconfirmed. `coverage A6583` → refuted, run this build. That is a linkage artefact of an articles-only cache with blank DME MAC code columns, not a CMS (Centers for Medicare & Medicaid Services) finding claim 12unconfirmed. No payer outside Medicare FFS (fee-for-service) has been read claim 35unconfirmed	claim 42verified
2f	Ex-US pathway — DE NUB/G-DRG, UK NICE (National Institute for Health and Care Excellence)/OPCS-4	Permanently unconfirmed, and not under-researched. `launch_jurisdiction:` is US. No connector in this repo reaches a non-US payment system, and no claim in the candidate speaks to one in any direction	— none

Pillars on verified claims: 3/6 · on assumptions: 0 · queued as research: 0

The other three are one unconfirmed claim (2b), one unverified proposition written back this build (2c), and one permanent blank (2f). The three verified pillars are code, bundling and benefit category. None of them says whether the manufacturer makes money, and 2b is the one that does.

Three distinctions this section exists to keep apart, because collapsing any of them turns a dead pathway into a green one:

A code existing is not payment, and payment is not coverage. Here all three have something behind them, and still none of them names a manufacturer price.
A packaged OPPS code and an inpatient DRG case both pay the facility nothing extra. That trap does not bite this device, which is dispensed to the home and paid per item.
2f is permanently unconfirmed, not "needs more research".

Verdicts from checks run this build that came back unusable or needed reading:

python3 -m connectors rvu A6583 → refuted (status X). This is correct for a DMEPOS item and is not a verdict on payment.
python3 -m connectors coverage A6583 → refuted. It is a cache-linkage artefact, as the candidate's own Verifier notes record.
python3 -m connectors apc A6583 → unconfirmed, missing cache.
python3 -m connectors icd I89.0 → unconfirmed, missing data/icd10cm.csv. It would have been a population check only, never a payment one.
cpt was not run. No CPT (Current Procedural Terminology) code is in question; A6583 is HCPCS Level II.

The money model

No market model exists for idea-009, so there is no derivation to link. The legs below are quoted from the file and deliberately not multiplied together. A size is a chain, and building that chain belongs to /market-model idea-009, not here.

Line	Figure	Backing
Medicare FFS volume floor, A6583, national, data year 2024	80,433 wraps billed / 24,631 beneficiaries	claim 15verified
Wraps billed per beneficiary, same file and year	≈3.3 (80,433 ÷ 24,631), early uptake in the benefit's first payable year	claim 15verified
Comparator FFS volume, below-knee stockings A6552 / A6553 / A6554, same year	7,836 / 7,528 / 290 services	claim 57unverified
Volume outside Medicare FFS (MA (Medicare Advantage), Medicaid, commercial, VA, cash)	unmeasured; assumed to be more than half of US units	[assumption A5]
Frequency allowance per body area	three daytime items per 6 months, two nighttime per 24 months	claim 45unconfirmed
Medicare allowed per wrap	$160.13 non-rural, July 2026	claim 11verified
Beneficiary coinsurance per wrap	≈$32.03 (20% of the allowed amount)	claim 11verified
Comparator allowed per stocking	A6552 $57.97 · A6553 $226.38	claim 58unverified
Manufacturer net price per wrap	the allowable less the dispensing supplier's margin; neither measured, no price set here	[assumption A3]
Manufacturer landed unit cost	unmeasured	[assumption A4]
Manufacturer gross margin per wrap	positive or not, unestablished	claim 31unconfirmed
Share won	10-20% within five years (the Generator's figure, carried as the file states it; not this case's estimate)	claim 17unconfirmed
Number of suppliers to sell to	assumed concentrated: fewer than 100 suppliers carrying over half of A6583 services	[assumption A1]

What the table does and does not say. Two volume legs and two price legs are on primary CMS files claim 15verified, claim 11verified, claim 57unverified, claim 58unverified. Every leg that turns them into manufacturer revenue is an assumption or an unconfirmed claim [assumption A3], [assumption A4], claim 31unconfirmed, claim 17unconfirmed. The FFS count is a floor on US volume, never a market size, and the first payable year may be catching an uptake curve that is still climbing claim 15verified.

State the market and adoption verdicts explicitly:

python3 -m connectors market "obtainable share of below-knee lymphedema wrap volume through DMEPOS suppliers and certified fitters, 10-20% within five years against four incumbents" → unverifiable. There is no free authoritative source claim 17unconfirmed.
python3 -m connectors market "US non-Medicare-FFS volume of below-knee adjustable-strap compression wraps" → unverifiable [assumption A5].
python3 -m connectors adoption "DMEPOS suppliers billing A6583 would add a fifth manufacturer's below-knee wrap to their dispensed range" → unverifiable. It needs primary research claim 24unconfirmed.

Path to first revenue

First dollar comes from: a DMEPOS supplier buying wraps to dispense under A6583 (Routes A and B differ on whether that supplier is a third party or the manufacturer), an incumbent licensing the indicator (Route C), or a cash buyer (Route D) claim 44verified.
What must exist first, common to every route:
- establishment registration and device listing under 21 CFR 807.20, which the exemption does not excuse claim 22unconfirmed;
- the device must actually sit inside 21 CFR 880.5780(b). The regulation identifies a device "constructed of elastic material", and this one is inelastic by design claim 6unconfirmed;
- 21 CFR 880.9 must not fire on lay self-application or on a different fundamental technology claim 38unconfirmed. If either of the last two goes against the candidate, every route below needs a premarket submission. No predicate is identified for that and no prior De Novo (De Novo classification request) exists claim 56unconfirmed. The calendar and the capital are then a different business, not a longer version of this one.
What must exist first, product-side: tension retention across the wear period claim 37unconfirmed, indicator tolerance across the circumference range and across lots claim 39unconfirmed, and durability through laundering claim 40unconfirmed. None has test data.
Calendar to first dollar: no month figure is carried anywhere in the file, and this case adds none. The proposition that it is short enough to plan against is itself unconfirmed claim 51unconfirmed.
Capital to first dollar: no dollar figure is carried, and this case adds none claim 52unconfirmed.

Routes

Four routes. Order is alphabetical by label and carries no ranking. Never ranked, never picked. Choosing is Tier 3.

Route A — Wholesale to third-party DMEPOS suppliers and certified fitters

Requires: the common regulatory premise above; the wrap reaching A6583 in the PDAC's view claim 32unconfirmed; suppliers and fitters willing to stock a further brand claim 24unconfirmed; a wholesale price that clears unit cost [assumption A3], [assumption A4]; and a supplier base concentrated enough to reach with a small sales effort [assumption A1].
Costs: tooling, fitter training and supplier onboarding, none of them priced claim 52unconfirmed. The manufacturer takes a wholesale margin, not the allowable [assumption A3].
Killed by: A4 returning a landed unit cost at or above the wholesale prices A3 finds incumbents charging suppliers. The entrant would then have no margin under a shared, fixed allowable.

Route B — Manufacturer enrols as its own DMEPOS supplier and bills A6583 directly

Requires: the common regulatory premise; CMS-855S enrolment and accreditation under 42 CFR 424.57, with billing permitted for a self-applied wrap shipped home without an in-person fitting as a condition of payment [assumption A6]; clinicians directing prescriptions to it claim 25unconfirmed; and collection of the 20% coinsurance claim 53unconfirmed.
Costs: everything in Route A's product-side list, plus supplier enrolment, accreditation, claims operations and coinsurance collection. None is priced claim 52unconfirmed. It captures the allowable rather than a wholesale price claim 11verified.
Killed by: the supplier standards or the DME MAC lymphedema policy article making an in-person fitting or dispensing condition part of payment, so that A6 is false.

Route C — License the tension-calibration indicator to an incumbent

Requires: a patentable indicator [assumption A7]. The field is unexamined, not clear claim 19unconfirmed, and one incumbent has an indicator filing on record as a lead claim 41unconfirmed. It also needs an incumbent willing to pay rather than build its own claim 54unconfirmed, claim 34unconfirmed.
Costs: patentability search, filing and prosecution, plus the regulatory scoping and module validation a licensee would need to see. None is priced claim 54unconfirmed. It needs no supplier enrolment and no PDAC listing of the entrant's own product.
Killed by: a patentability search that finds the elongation-window indicator anticipated, leaving nothing to license. The Essity "compression garment with indicator" family is the first document to read claim 41unconfirmed.

Route D — Cash-pay, outside Medicare billing

Requires: the common regulatory premise; patients or caregivers paying out of pocket above the coinsurance a covered route would leave them owing claim 55unconfirmed; and a direct channel that gets the ABI/arterial-status screening done without a fitter claim 28unconfirmed, claim 21unconfirmed.
Costs: tooling and a direct-to-consumer channel. None is priced. It carries no PDAC or CMS-855S cost claim 52unconfirmed. It competes against a Medicare benefit that already pays for the same item category claim 42verified.
Killed by: a priced pre-order or deposit test in the indicated population that finds too few buyers at any price above the coinsurance. That falsifies claim 55unconfirmed.

Assumption register

Every assumption cited above, with what would settle it and who could run it. All seven are appended to the candidate as unverified claims 60-66, in order. Claims 57-59 were appended in the same pass but are connector-readable propositions, not assumptions. They are cited as claims and wait for the Verifier to tag them.

#	Assumption	Falsifier	Owner
A1	In Medicare FFS data year 2024, fewer than 100 DMEPOS suppliers accounted for more than half of national A6583 services (claim 60unverified)	The CMS Medicare DMEPOS "by Supplier and Service" file for data year 2024, loaded into `data/` and sorted by A6583 services. It is a registry read, not a survey	Scout (place the file); Verifier (read it)
A2	The PDAC DMECS product classification list for A6583 names at least one manufacturer beyond medi, Essity/BSN, Sigvaris and Solaris (claim 61unverified)	Read the PDAC DMECS product classification lookup for A6583 and count distinct manufacturers. This is the revealed-behaviour twin of "would an entrant get onto the code and into the channel?"	Scout / human (a public lookup, no connector)
A3	Incumbents sell A6583 wraps to DMEPOS suppliers at wholesale prices below the $160.13 allowable, leaving the supplier a positive margin (claim 62unverified)	Written wholesale quotes or price lists for a below-knee adjustable-strap wrap from two or more of the four named incumbents, obtained through an accredited DMEPOS supplier	80_commercial with a DMEPOS supplier contact
A4	A below-knee inelastic strap wrap with printed elongation windows can be produced at a landed unit cost below incumbent wholesale prices (claim 63unverified)	Quotes from two or three contract textile manufacturers on a tech pack at stated volumes, compared line by line with A3's prices	Engineering / operations
A5	Medicare FFS accounts for less than half of US below-knee adjustable-strap wraps dispensed each year (claim 64unverified)	A licensed all-payer claims count of A6583 units by payer type, or an incumbent's disclosed US payer mix. `market` returns unverifiable, so this needs a human-attached licensed source	80_commercial (licensed data)
A6	A manufacturer enrolled and accredited as a DMEPOS supplier may bill A6583 for its own self-applied wrap shipped home, with no in-person certified-fitter fitting as a condition of payment (claim 65unverified)	`regulation 424.57 --title 42` on the supplier standards (the section read this build). Then a human read of the DME MAC lymphedema compression policy article for any fitting or dispensing condition	Verifier (CFR text); market access (policy article)
A7	No earlier patent or publication anticipates a printed strap elongation window that aligns at a fixed design tension on a below-knee wrap (claim 66unverified)	A professional patentability search in CPC A61F13/08, starting with Essity family 81386942 ("compression garment with indicator"), 3M WO2014014672A1 and Smith & Nephew CA2215142A1	Patent counsel (Tier 3)

Cheapest falsifier: A2. It is one public PDAC lookup, and either answer moves three routes. If the list shows no entrant beyond the four since 2024, that bears on Routes A and B and on the share leg. If it shows entrants, it also names who got onto the code without incumbency, which is the question claim 32unconfirmed asks.

Where this case outruns the file

Every figure or position with no verified claim behind it, gathered in one place. These are the work items.

Manufacturer price per wrap. Nothing in the file reads a wholesale or transfer price. The allowable is a ceiling on the supplier, not a price to the manufacturer (A3).
Manufacturer unit cost. Nothing in the file reads it (A4).
Gross margin. It needs both of the above; claim 31unconfirmed stays unconfirmed until they exist.
Share won. The Generator's range is market-unverifiable by design, and this case adds no estimate of its own.
Volume beyond Medicare FFS. Unmeasured (A5). The FFS count is a floor.
Channel structure. How many suppliers carry the code (A1), and whether any entrant has reached it (A2).
Calendar and capital to first dollar. No figure exists in the file, and none is added (claims 51, 52).
The regulatory premise under all four routes. Inelastic versus "constructed of elastic material", and § 880.9 lay use (claims 6, 38). A 513(g) or regulatory counsel settles it. No agent does.
The refuted positioning. The 30-50 mmHg descriptor band (claims 8, 36) is gone. Whatever pressure specification the product carries is now a design choice with no reimbursement anchor, and inelastic wraps may cap near 30 mmHg at rest (claim 48unconfirmed, an unconfirmed literature lead).
Who chooses and who pays the coinsurance. Fitter uptake, clinician acceptance and coinsurance tolerance are all adoption-unverifiable (claims 24, 25, 53).
Stocking comparator volumes and allowables, and the PFS (physician fee schedule) status-X reading. These were read by connector this build and written back untagged (claims 57, 58, 59). They are cited as unverified until the Verifier passes them.

Words on this page16 abbreviation(s) and code(s), with what each stands for — copied from _shared/plain-language.md

A####: a HCPCS code for a supply — one billing code for a supply or an accessory; the letter A and four digits
CMS: Centers for Medicare & Medicaid Services — the US agency that runs Medicare, and so decides what Medicare pays for
CPT: Current Procedural Terminology — the US billing codes for what a clinician does; owned by the American Medical Association
De Novo: De Novo classification request — the FDA route for a new, lower-risk device with no comparable product to point at; longer than a 510(k), usually needs clinical data
DME MAC: durable medical equipment Medicare administrative contractor — one of the four regional contractors that process Medicare's home-equipment claims and write its local coverage rules
DMEPOS: durable medical equipment, prosthetics, orthotics and supplies — the Medicare benefit and fee schedule that home equipment is paid under
FFS: fee-for-service — the traditional form of Medicare that pays per item or service
HCPCS: Healthcare Common Procedure Coding System — the US billing codes for equipment, supplies and some services; a code is how a payer recognises what to pay for
MA: Medicare Advantage — Medicare delivered through a private insurer; must cover at least what Medicare covers
Medicare Advantage: Medicare Advantage — Medicare delivered through a private insurer; must cover at least what Medicare covers
Medicare Part B: Medicare Part B — the part of Medicare that pays for outpatient care and equipment used at home
mmHg: millimetres of mercury — the unit blood pressure, and the suction of a wound pump, are measured in
NICE: National Institute for Health and Care Excellence — the English body whose guidelines say what the NHS should use
PDAC: Pricing, Data Analysis and Coding contractor — the Medicare contractor that decides which billing code a specific product falls under
PFS: physician fee schedule — the Medicare price list for what clinicians do
TAM: total addressable market — how much money the whole market would be worth if every possible buyer bought

Generated from knowledge-base/commercial/idea-009.md by engine/scripts/build_review.py on 2026-10-04. This page is a view — edit the source file and rebuild, never edit here.